Centro de Imagem Diagnósticos S.A - Asset Resilience Ratio

Latest as of September 2025: 4.77%

Centro de Imagem Diagnósticos S.A (AALR3) has an Asset Resilience Ratio of 4.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

R$144.46 Million
≈ $28.35 Million USD Cash + Short-term Investments

Total Assets

R$3.03 Billion
≈ $594.03 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Centro de Imagem Diagnósticos S.A's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Centro de Imagem Diagnósticos S.A to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Centro de Imagem Diagnósticos S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AALR3 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents R$96.94 Million 3.2%
Short-term Investments R$47.52 Million 1.57%
Total Liquid Assets R$144.46 Million 4.77%

Asset Resilience Insights

  • Limited Liquidity: Centro de Imagem Diagnósticos S.A maintains only 4.77% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Centro de Imagem Diagnósticos S.A Industry Peers by Asset Resilience Ratio

Compare Centro de Imagem Diagnósticos S.A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Chemclin Diagnostics Co. Ltd. A
SHG:688468
Diagnostics & Research 15.34%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Bcal Diagnostics Ltd
AU:BDX
Diagnostics & Research 0.00%
Check Cap Ltd
NASDAQ:CHEK
Diagnostics & Research 70.29%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Cryosite Ltd
AU:CTE
Diagnostics & Research 5.65%

Annual Asset Resilience Ratio for Centro de Imagem Diagnósticos S.A (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Centro de Imagem Diagnósticos S.A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.31% R$124.54 Million
≈ $24.44 Million
R$2.89 Billion
≈ $566.92 Million
-2.75pp
2023-12-31 7.06% R$188.43 Million
≈ $36.97 Million
R$2.67 Billion
≈ $523.87 Million
+2.16pp
2022-12-31 4.89% R$128.02 Million
≈ $25.12 Million
R$2.62 Billion
≈ $513.20 Million
+0.64pp
2021-12-31 4.26% R$108.27 Million
≈ $21.24 Million
R$2.54 Billion
≈ $498.83 Million
-3.36pp
2020-12-31 7.62% R$193.64 Million
≈ $38.00 Million
R$2.54 Billion
≈ $498.51 Million
+4.55pp
2019-12-31 3.07% R$73.71 Million
≈ $14.46 Million
R$2.40 Billion
≈ $471.14 Million
-0.48pp
2018-12-31 3.55% R$78.44 Million
≈ $15.39 Million
R$2.21 Billion
≈ $433.53 Million
+1.97pp
2017-12-31 1.58% R$36.16 Million
≈ $7.10 Million
R$2.28 Billion
≈ $448.36 Million
-3.45pp
2016-12-31 5.04% R$109.10 Million
≈ $21.41 Million
R$2.17 Billion
≈ $425.07 Million
+4.80pp
2015-12-31 0.24% R$3.67 Million
≈ $720.51K
R$1.54 Billion
≈ $301.46 Million
-0.22pp
2014-12-31 0.46% R$6.71 Million
≈ $1.32 Million
R$1.46 Billion
≈ $287.23 Million
--
pp = percentage points

About Centro de Imagem Diagnósticos S.A

SA:AALR3 Brazil Diagnostics & Research
Market Cap
$99.83 Million
R$508.76 Million BRL
Market Cap Rank
#19172 Global
#181 in Brazil
Share Price
R$3.34
Change (1 day)
+0.60%
52-Week Range
R$2.56 - R$6.76
All Time High
R$24.30
About

Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more